Clinical Trial: Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hidradenitis Suppurativa
Study Type: INTERVENTIONAL
Official Title: Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
Brief Summary:
HS is relatively common in the United States with a prevalence of 0.1-1.0%. 1 HS has a dramatic impact on quality of life, significantly more so than other chronic skin diseases, such as psoriasis or atopic dermatitis (AD).HS also has a large economic impact, due to frequent emergency department and inpatient care utilization, and re-hospitalization rates similar to congestive heart failure.Unfortunately, few treatment options are effective.There is only one currently FDA-approved treatment, adalimumab, but only…
Read more